Ind-Swift Laboratories share news, announcements and annual reports
NSE: INDSWFTLABBSE: 532305Pharmaceuticals & BiotechnologySmall Cap
Ind-Swift Laboratories Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 1997 on NSE, Mar 2000 on BSE
Last close ₹368.80up ₹31.75 (9.42%)BSE ₹368.25
Share price at the NSE close on 27 Oct 2026. Previous close ₹337.05.
27 Oct: open ₹335.00, high ₹376.00, low ₹335.00
52-week range of traded prices to 27 Oct 2026
₹87.15Low, 31 Dec 2025₹424.75High, 30 Sep 2026
- Under NSE's long-term additional surveillance, stage I, on the list for 27 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 29 Oct 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹3,207 Cr1,404th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 55.95
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹11 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 46.77
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.32
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 4.5%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹11 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 5.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 2.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 8,50,81757.4% delivered
Ind-Swift Laboratories disputes and clarifications
20 filed, newest first.
Aug 2026
28 Aug · Legal
The exchange asked on 26 Aug 2026
Apr 2026
13 Apr · Legal
The exchange asked on 8 Apr 2026
Aug 2023
28 Aug · Legal
The exchange asked on 25 Aug 2023
Jan 2021
9 Jan · Legal
The exchange asked on 8 Jan 2021
Sep 2020
22 Sep · Legal
The exchange asked on 21 Sep 2020
Aug 2020
5 Aug · Legal
Exchange has sought clarification from Ind-Swift Laboratories Limited with respect to announcement dated 04-Aug-2020, regarding "Intimation of Fire in Corporate Office of the Company pursuant to Reg. 30 of SEBI (LODR) Regulations, 2015'.". On basis of above the Company is required to clarify following: 1. Expected quantum of loss/damage caused; 2. Whether loss/damage covered by insurance or not including amount; The response of the Company is awaited.
Feb 2020
14 Feb · Legal
Exchange has sought clarification from Ind-Swift Laboratories Limited with respect to announcement dated 13-Feb-2020, regarding Appointment of Dr.Ashwani K Vig and Sh. Sahil Munjal.". On basis of above the Company is required to clarify following: 1. Date of appointment & term of appointment 2. Brief profile 3. Disclosure of relationships between directors 4. Whether intimated in 24hrs. The response of the Company is awaited.
Jul 2018
8 Jul · Legal
Exchange has sought clarification from Ind-Swift Laboratories Limited with respect to announcement dated 05-Jul-2018, regarding " Ind-Swift Laboratories Limited has informed the Exchange regarding 'Intimation of Minor Fire at R&D Centre, Mohali, Punjab' pursuant to regulation 30 of the SEBI (LODR) Regulations, 2015'.". On basis of above the Company is required to clarify following: 1. Whether loss/damage covered by insurance or not including amount; 2. Expected quantum of loss/damage caused; The response of the Company is awaited.
Jun 2018
4 Jun · Legal
Exchange has sought clarification from Ind-Swift Laboratories Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Standalone Reconciliation of profit and loss not submitted -2. Standalone Reconciliation of Equity not submitted -3. Consolidated Reconciliation of profit and loss not submitted -4. Consolidated Reconciliation of Equity not submitted The response of the Company is awaited.
May 2018
3 May · Legal
Exchange has sought clarification from Ind-Swift Laboratories Limited with respect to announcement dated 02-May-2018, regarding " Ind-Swift Laboratories Limited has informed the Exchange regarding Board meeting held on May 02, 2018.". On basis of above the Company is required to clarify following: 1. Details of redemption of preference shares indicating the manner of redemption (whether out of profits or out of fresh issue) and debentures. 2. Details of any letter or comments regarding payment/non-payment of interest, principal on due dates, or any other matter concerning the security and /or the assets along with its comments thereon, if any; 3. Delay in payment of interest / principal amount for a period of more than three months from the due date or default in payment of interest / principal; 4. Special right/interest/privileges attached to the instrument and changes thereof; 5. Charge/security, if any, created over the assets; 6. Coupon/interest offered, schedule of payment of coupon/interest and principal; 7. Tenure of the instrument - date of allotment and date of maturity; 8. Whether proposed to be listed? If yes, name of the stock exchange(s); The response of the Company is awaited.
Dec 2017
26 Dec · Legal
The exchange asked on 22 Dec 2017
Feb 2017
9 Feb · Legal
Exchange has sought clarification from Ind-Swift Laboratories Limited with respect to announcement dated 09-Feb-2017, regarding a fire broke out in one of the manufacturing block of the Company situated at Derabassi Punjab. There was no causality but loss of goods for which the company is assessing the value of the loss. ". On basis of above the Company is required to clarify following: 1. Insurance amount claimed and realized by the listed entity for the loss/damage;2. The actual amount of damage caused due to the natural calamity or other force majeure events;3. Details of steps taken to restore normalcy and the impact of the natural calamity/other force majeure events on production or service, financials of the entityThe response of the Company is awaited.
Dec 2011